Literature DB >> 4642734

Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus.

O Castro, L R Farber, L P Clyne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4642734     DOI: 10.7326/0003-4819-77-4-543

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  Autoantibodies with enzymatic properties in human autoimmune diseases.

Authors:  Bharath Wootla; Sébastien Lacroix-Desmazes; Arthur E Warrington; Allan J Bieber; Srini V Kaveri; Moses Rodriguez
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

2.  Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management.

Authors:  Massimo Franchini; Giancarlo Castaman; Antonio Coppola; Cristina Santoro; Ezio Zanon; Giovanni Di Minno; Massimo Morfini; Elena Santagostino; Angiola Rocino
Journal:  Blood Transfus       Date:  2015-06-24       Impact factor: 3.443

3.  Combined homozygous factor H and heterozygous C2 deficiency in an Italian family.

Authors:  M Brai; G Misiano; S Maringhini; I Cutaja; G Hauptmann
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

4.  Standardization of diagnostic materials. 3. Laboratory reagents and coagulation assay procedures.

Authors:  E A Loeliger
Journal:  Bull World Health Organ       Date:  1973-06       Impact factor: 9.408

5.  Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII.

Authors:  G R Milner; P J Holt; J Bottomley; J E Maciver
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

6.  Arterial thrombotic manifestations in young women associated with the lupus anticoagulant.

Authors:  E J Ter Borg; J Van der Meer; J T De Wolf; M H Van Leeuwen; C G Kallenberg
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.